Skip to main content
. 2022 Mar 4;355(5):2100360. doi: 10.1002/ardp.202100360

Figure 23.

Quinoline and quinazoline alkaloids against three potential targets of SARS‐CoV‐2. SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2

graphic file with name ARDP-355-2100360-g008.jpg

graphic file with name ARDP-355-2100360-g025.jpg

graphic file with name ARDP-355-2100360-g029.jpg